These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21626113)

  • 1. Biphasic bone substitute and fibrin sealant for treatment of benign bone tumours and tumour-like lesions.
    Reppenhagen S; Reichert JC; Rackwitz L; Rudert M; Raab P; Daculsi G; Nöth U
    Int Orthop; 2012 Jan; 36(1):139-48. PubMed ID: 21626113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Filling of bone defects using biphasic macroporous calcium phosphate ceramic. Apropos of 23 cases].
    Gouin F; Delécrin J; Passuti N; Touchais S; Poirier P; Bainvel JV
    Rev Chir Orthop Reparatrice Appar Mot; 1995; 81(1):59-65. PubMed ID: 7569179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite ceramic bone graft substitute in the treatment of locally aggressive benign bone tumours.
    Schindler OS; Cannon SR; Briggs TW; Blunn GW
    J Orthop Surg (Hong Kong); 2008 Apr; 16(1):66-74. PubMed ID: 18453663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lyophilized small-segment allogeneic bone in repairing bone defect due to benign bone tumor and tumor-like lesions after resection and curettage].
    Guo S; Feng W; Jia Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Aug; 21(8):789-92. PubMed ID: 17882868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous calcium sulphate as bone graft for voids following open curettage of bone tumours.
    Johnson LJ; Clayer M
    ANZ J Surg; 2013 Jul; 83(7-8):564-70. PubMed ID: 22925525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure reconstruction with bone substitute pellets graft following curettage and high-speed burring for chondroblastoma of the proximal tibia: a case report and review of the literature.
    Wu CC; Yu CT
    Orthop Surg; 2011 Nov; 3(4):271-5. PubMed ID: 22021146
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment alternatives and clinical outcomes of bone filling after benign tumour curettage. A systematic review.
    Gava NF; Engel EE
    Orthop Traumatol Surg Res; 2022 Jun; 108(4):102966. PubMed ID: 34033919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to full weight-bearing with the use of a calcium sulfate-calcium phosphate bone substitute as a bone void filler following extended curettage in the treatment of primary benign bone tumours.
    Gyemi L; Selznick A; Petrisor B; Ghert M
    J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254200. PubMed ID: 38733211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel fully interconnected porous hydroxyapatite ceramic in surgical treatment of benign bone tumor.
    Tamai N; Myoui A; Kudawara I; Ueda T; Yoshikawa H
    J Orthop Sci; 2010 Jul; 15(4):560-8. PubMed ID: 20721726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of juvenile bone cysts by curettage and filling of the cavity with BAS-0 bioactive glass-ceramic material].
    Sponer P; Urban K
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):214-9. PubMed ID: 15456099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions of artificial bone graft substitutes: lessons learned from using tricalcium phosphate geneX®.
    Friesenbichler J; Maurer-Ertl W; Sadoghi P; Pirker-Fruehauf U; Bodo K; Leithner A
    Clin Orthop Relat Res; 2014 Mar; 472(3):976-82. PubMed ID: 24078171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of bioactive glass-ceramic implanted into long bone defects: a scintigraphic study.
    Sponer P; Urban K; Urbanová E; Karpas K; Mathew PG
    J Pediatr Orthop B; 2010 Jan; 19(1):102-7. PubMed ID: 19887965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alloplastic cancellous bone replacement and fibrin glue in hand surgery].
    Wolter TP; Fuchs P; Pallua N
    Handchir Mikrochir Plast Chir; 2010 Oct; 42(5):317-21. PubMed ID: 20827666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone defects following curettage do not necessarily need augmentation.
    Hirn M; de Silva U; Sidharthan S; Grimer RJ; Abudu A; Tillman RM; Carter SR
    Acta Orthop; 2009 Feb; 80(1):4-8. PubMed ID: 19234881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does bone marrow affect the radiological outcome when added to biphasic ceramic graft in treatment of benign bone lesions?
    El-Adl G; Ali AM
    Eur J Orthop Surg Traumatol; 2013 Jan; 23(1):13-20. PubMed ID: 23412403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours.
    Razii N; Docherty LM; Halai M; Mahendra A; Gupta S
    Curr Oncol; 2023 Mar; 30(4):3697-3707. PubMed ID: 37185394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical observation on nano-hydroxyapatite and polyamide 66 composite in repairing bone defect due to benign bone tumor].
    Liang X; Jiang D; Ni W
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Aug; 21(8):785-8. PubMed ID: 17882867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Three-in-One minimally invasive approach to surgical treatment of pediatric pathological fractures with wide bone loss through bone cysts: ESIN, curettage and packing with injectable HA bone substitute. A retrospective series of 116 cases.".
    Guida P; Ragozzino R; Sorrentino B; Casaburi A; D'Amato RD; Federico G; Guida L; Assantino A
    Injury; 2016 Jun; 47(6):1222-8. PubMed ID: 27105837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Repairing bone defects of benign bone neoplasm by grafting of bioactive glass combined with autologous bone marrow].
    Liu H; Sun J; Wang Y; Yang X; Zhu E
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Nov; 22(11):1349-53. PubMed ID: 19068605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of ultraporous β-tricalcium phosphate (vitoss) as bone graft substitute for cavitary defects in benign and low-grade malignant bone tumors.
    Van Hoff C; Samora JB; Griesser MJ; Crist MK; Scharschmidt TJ; Mayerson JL
    Am J Orthop (Belle Mead NJ); 2012 Jan; 41(1):20-3. PubMed ID: 22389890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.